Ferrous gluconate

DB14488ApprovedInvestigationalSmall moleculeAntianemia Drugs Iron Preparations

Ferrous gluconate is a medication used to treat iron-deficiency anemia.

Mechanism: Iron is necessary for the production of hemoglobin. Iron-deficiency can lead to decreased production of hemoglobin and a microcytic, hypochromic anemia.
Curator reviewed
Primary indication: Used in preventing and treating iron-deficiency anemia.Curator reviewed · 14 structured indications
Formula / weight: C₁₂H₂₂FeO₁₄ · 446.139 g/mol (avg)
First approval: Canada, 1998
Also known as: Ferric Gluconate

Resolves to

Compound

Clinical / RWD

Structure

[Fe++].[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C([O-])=O.[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C([O-])=O

Targets

What you can answer from here — as of September 13, 2026

13Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

128Drug interactionsStructured to mechanism, not free text

12Clinical trialsPhase, status and sponsor resolved per trial

14Structured indicationsCondition, population, route and combination as fields, not prose

115Marketed productsAcross 9 countries and 72 labellers

2ATC codesIncluding every combination product, plus 11 drug categories

14+ReferencesStructured and connected to the statements they support

Which drugs share a target with Ferrous gluconate, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.